Supporting Publication
A Multidisciplinary Journal of Antiviral Agents, Natural Host Defence Mechanisms, Interferons and Antiviral Vaccines
An Official Publication of the International Society for Antiviral Research
Antiviral Research publishes full-length original articles, short definitive papers and review articles pertaining to the effective control of virus infections in animals and man as well as in plants or lower organisms. Its scope encompasses: -the mechanism of natural and acquired host resistance against virus infections, including aspecific cellular resistance, interferons, cellular and humoral immunity in virus infections, chemotherapeutics which influence host resistance; -the development of new vaccines or novel forms of serotherapy against viral diseases, including virological characterization of vaccine strains or vaccine preparations; preparation and characterization of antiviral immunoglobulins; safety and efficiency assessment; field trials; -the development of new antiviral chemotherapeutics, including chemistry; in vitro activity; mechanism of action; activity in animal model systems; clinical trials.
Editor-in-Chief
M. Bray, Bethesda, MD, USA
Editors
Dale Barnard, Logan, UT, USA
José Esté, Badalona (Barcelona), Spain
Subhash Vasudevan, Singapore, Singapore
Mark Prichard, Birmingham, AL, USA
Hui-Ling Yen, Pokfulam, Hong Kong
For further information please visit: http://www.journals.elsevier.com/antiviral-research/
Top 10 cited articles 2010-11
Weaver, S.C., Reisen, W.K.
Present and future arboviral threats
(2010) Antiviral Research, 85 (2), pp. 328-345. Cited 57 times.
Broder, S.
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
(2010) Antiviral Research, 85 (1), pp. 1-18. Cited 44 times.
de Béthune, M.-P.
Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989-2009)
(2010) Antiviral Research, 85 (1), pp. 75-90. Cited 43 times.
Tilton, J.C., Doms, R.W.
Entry inhibitors in the treatment of HIV-1 infection
(2010) Antiviral Research, 85 (1), pp. 91-100. Cited 37 times.
Menéndez-Arias, L.
Molecular basis of human immunodeficiency virus drug resistance: An update
(2010) Antiviral Research, 85 (1), pp. 210-231. Cited 37 times.
McColl, D.J., Chen, X.
Strand transfer inhibitors of HIV-1 integrase: Bringing IN a new era of antiretroviral therapy
(2010) Antiviral Research, 85 (1), pp. 101-118. Cited 35 times.
Wensing, A.M.J., van Maarseveen, N.M., Nijhuis, M.
Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance
(2010) Antiviral Research, 85 (1), pp. 59-74. Cited 32 times.
Cihlar, T., Ray, A.S.
Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine
(2010) Antiviral Research, 85 (1), pp. 39-58. Cited 31 times.
Esté, J.A., Cihlar, T.
Current status and challenges of antiretroviral research and therapy
(2010) Antiviral Research, 85 (1), pp. 25-33. Cited 30 times.
Wang, B., Dwyer, D.E., Blyth, C.C., Soedjono, M., Shi, H., Kesson, A., Ratnamohan, M., McPhie, K., Cunningham, A.L., Saksena, N.K.
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections
(2010) Antiviral Research, 87 (1), pp. 16-21. Cited 26 times.
Organized by
Supporting Journal